Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Cerilliant
Cantor Fitzgerald
Julphar
Harvard Business School
Moodys
Healthtrust
Federal Trade Commission
US Army

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,743,442

« Back to Dashboard

Summary for Patent: 6,743,442
Title: Melt-extruded orally administrable opioid formulations
Abstract:Bioavailable sustained release oral opioid analgesic dosage forms, comprising a plurality of multiparticulates produced via melt extrusion techniques are disclosed.
Inventor(s): Oshlack; Benjamin (New York, NY), Chasin; Mark (Manalapan, NJ), Huang; Hua-Pin (Englewood Cliffs, NJ), Sackler; David (Greenwich, CT)
Assignee: Euro-Celtique, S.A. (Luxembourg, LU)
Application Number:09/777,616
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form; Use;

Drugs Protected by US Patent 6,743,442

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,743,442

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 257375 ➤ Subscribe
Austria 356616 ➤ Subscribe
Austria 357909 ➤ Subscribe
Austria 397441 ➤ Subscribe
Austria 452627 ➤ Subscribe
Australia 4157096 ➤ Subscribe
Australia 4736299 ➤ Subscribe
Australia 6400199 ➤ Subscribe
Australia 705894 ➤ Subscribe
Australia 747389 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Harvard Business School
Accenture
Baxter
McKesson
Deloitte
Cipla
QuintilesIMS
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot